BC
BBH icon

Barnett & Company’s VanEck Biotech ETF BBH Stock Holding History

Barnett & Company’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-100
Closed -$12K – 344
2018
Q2 		$12K Hold
100
– – 0.01% 263
2018
Q1 		$12K Hold
100
– – 0.01% 262
2017
Q4 		$12K Hold
100
– – 0.01% 271
2017
Q3 		$13K Hold
100
– – 0.01% 271
2017
Q2 		$13K Hold
100
– – 0.01% 290
2017
Q1 		$12K Hold
100
– – 0.01% 279
2016
Q4 		$11K Hold
100
– – 0.01% 310
2016
Q3 		$12K Hold
100
– – 0.01% 318
2016
Q2 		$10K Hold
100
– – 0.01% 317
2016
Q1 		$10K Buy
+100
New +$10.4K 0.01% 329

Other funds holding BBH

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Barnett & Company's BBH Position: Q3 2018 in Review

Barnett & Company sold out of VanEck Biotech ETF (BBH) in Q3 2018, closing a stake of 100 shares — an estimated $12K sold.

Barnett & Company first reported a position in BBH in Q1 2016 and held it in 10 quarters. The position peaked at $13K in Q3 2017. 84 funds tracked by Wall St. Rank hold BBH as of Q3 2018.

  • Barnett & Company reported no remaining VanEck Biotech ETF position as of Q3 2018 after selling out during the quarter.
  • Barnett & Company sold 100 VanEck Biotech ETF shares in Q3 2018, an estimated $12K.
  • Barnett & Company first reported a position in VanEck Biotech ETF in Q1 2016 and held it in 10 quarters.
  • Barnett & Company's VanEck Biotech ETF position peaked at $13K in Q3 2017.
  • 84 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2018.

Based on Barnett & Company's 13F filing for Q3 2018, filed 2 Nov 2018.